Home
About Us
Products
Life Sciences Chemical, Speciality Chemicals
Cosmetics and Personal Care Products
Food, Beverages and Supplements
Toys and Child Care Products
FMCG and Retail Products
Pesticides and Antimicrobials
Fragrance and Aroma Products
Personal Accessories and Articles
Consumer Health Care Products
Cleaning and Hygiene Products
Food Contact Material
Medical Devices
Services
Authorised Representative (EU)
International Regulatory Affairs
Scientific and Technical Guidance
Product Stewardship and Innovation Support
Regulatory Compliance
Environmental Compliance
Regulatory Documentation and Traceability
Safety and Compliance Internal Audit
Hazard, Risk Assessment and Mitigation
Scientific Advocacy and Regulatory Strategy
Regulatory Approvals and Market Authorization
Poison Centre Notification (PCN), SCIP Notification
Label Harmonization and e-Label
Industries
Pharmaceutical
Consumer Healthcare
FMCG/Consumer Products
Chemicals
Manufacturing/Contract Manufacturing
Food Processing
Packaging
Natural Origin Products
Trending Updates
News
Regulatory Insights / Blogs / White Paper
Data Analytics
RI2 Actionable Intelligence
e-Label
Search
Trending Updates
All
News
Regulatory insights/blogs/White Paper
Data analytics
News
2025
2024
2023
2022
Nov 18, 2025
Consultation on the International Council for Harmonisation Guideline Q3E for Extractables
The Medicines and Healthcare products Regulatory Agency (MHRA), on behalf of the International Council for Harmonisation
Nov 18, 2025
HSA warns against HW Beauty drink with undeclared medicinal ingredients
HSA Singapore warned consumers not to use the product after laboratory testing detected potent undeclared medicinal subs
Nov 18, 2025
Four Substances Recommended for REACH Authorisation
The European Chemicals Agency (ECHA) has issued a new recommendation to include four additional substances in the REACH
Nov 18, 2025
MHRA launches consultation on ICH Q3E guideline for extractables and leachables
The UK MHRA has opened a public consultation on the draft ICH Q3E guideline, which outlines a harmonised, risk-based fra
Nov 17, 2025
EFSA sets health-based guidance value for Δ8-THC
EFSA issued a scientific opinion deriving a health-based guidance value for Δ8-THC and assessing its presence in food an
Nov 17, 2025
ECHA recommends four substances for REACH authorisation
ECHA has recommended adding four SVHCs to Annex XIV of REACH, meaning future uses will require authorisation. The substa
Nov 17, 2025
FDA Drug Competition Action Plan
The FDA Drug Competition Action Plan is a strategic initiative developed by the U.S. Food and Drug Administration to enh
Nov 17, 2025
TGA releases device reforms consumer working group statement
The TGA published discussions from the Medical Device Reforms Consumer Working Group highlighting expectations for stron
1
2
3
4
5
...
87
›